Home
LIMNW vs GPC Comparison

LIMNW vs GPC Comparison

Compare LIMNW & GPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LIMNW

GPC

Machine Learning Prediction

ML Decision
LIMNW
GPC

Stock Information

Founded
LIMNW N/A
GPC 1928

Country
LIMNW United States
GPC United States

Employees
LIMNW N/A
GPC N/A

Industry
LIMNW
GPC Automotive Aftermarket

Sector
LIMNW
GPC Consumer Discretionary

Exchange
LIMNW Nasdaq
GPC Nasdaq

Market Cap
LIMNW N/A
GPC N/A

IPO Year
LIMNW N/A
GPC N/A

Fundamental

Price
LIMNW $0.09
GPC $128.27

Analyst Decision
LIMNW
GPC Buy

Analyst Count
LIMNW 0
GPC 7

Target Price
LIMNW N/A
GPC $130.86

AVG Volume (30 Days)
LIMNW N/A
GPC 1.3M

Earning Date
LIMNW N/A
GPC 07-22-2025

Dividend Yield
LIMNW N/A
GPC 3.21%

EPS Growth
LIMNW N/A
GPC N/A

EPS
LIMNW N/A
GPC 6.09

Revenue
LIMNW N/A
GPC $23,569,007,000.00

Revenue This Year
LIMNW N/A
GPC $3.56

Revenue Next Year
LIMNW N/A
GPC $3.53

P/E Ratio
LIMNW N/A
GPC $21.06

Revenue Growth
LIMNW N/A
GPC 1.99

52 Week Low
LIMNW N/A
GPC $104.01

52 Week High
LIMNW N/A
GPC $149.22

Technical

Relative Strength Index (RSI)
LIMNW N/A
GPC 62.52

Support Level
LIMNW N/A
GPC $124.76

Resistance Level
LIMNW N/A
GPC $128.39

Average True Range (ATR)
LIMNW 0.00
GPC 2.56

MACD
LIMNW 0.00
GPC 0.06

Stochastic Oscillator
LIMNW 0.00
GPC 86.82

About LIMNW Liminatus Pharma Inc. Warrants

Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.

Share on Social Networks: